Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
NovaBay Pharmaceuticals, Inc. | CFO | Common Stock | 127K | $231K | $1.81 | Dec 6, 2021 | Direct |
EYENOVIA, INC. | Chief Financial Officer | Stock Option (right to buy) | 200K | Aug 30, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
EYEN | EYENOVIA, INC. | Aug 30, 2024 | 1 | $0 | 4 | Sep 3, 2024 | Chief Financial Officer |
EYEN | EYENOVIA, INC. | Aug 30, 2024 | 0 | $0 | 3 | Sep 3, 2024 | Chief Financial Officer |
NBY | NovaBay Pharmaceuticals, Inc. | Feb 15, 2023 | 0 | $0 | 4 | Feb 17, 2023 | CFO |
NBY | NovaBay Pharmaceuticals, Inc. | Dec 3, 2021 | 2 | $20K | 4 | Dec 6, 2021 | CFO |
NBY | NovaBay Pharmaceuticals, Inc. | May 4, 2021 | 1 | -$61.8K | 4 | May 7, 2021 | CFO |